• CTC BIO corrected its 2025 annual report on November 13, 2026, specifying its six-month treasury-share plan.
• The plan calls for retaining 272,245 common shares from January 1 through June 30, 2026, with no acquisitions, disposals or cancellations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTC BIO Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261113000201), on November 13, 2026, and is solely responsible for the information contained therein.